Source: American Academy of Family Physicians
In this episode of CME on the Go, host Lauren Brown-Berchtold, MD, FAAFP, engages in a detailed discussion with Robert Grant, MD, MPH, a pulmonary and critical care specialist, about the potential of psychedelics in mental health treatment. The conversation centers on the medical uses of ketamine, its history, safety, and practical approaches for its integration into clinical care.
Dr. Grant also shares his personal journey from HIV research to exploring alternative treatments for PTSD and mental health crises.
This episode provides valuable insights for family physicians interested in incorporating ketamine as a therapeutic option for patients with treatment-resistant depression and suicidal ideation.
Learning Objectives
- Define the term psychedelics and describe the main types of psychedelic substances and their effects on the brain and body.
- Compare and contrast the potential benefits and risks of using psychedelics for treating various mental health conditions, such as depression, anxiety, PTSD, and addiction.
- Identify the legal and ethical issues involved in prescribing, administering, or recommending psychedelics to patients in different jurisdictions and settings.
- Evaluate the current evidence and best practices for integrating psychedelics into a holistic and patient-centered approach to mental health care.
After listening to the podcast episode, claim 0.5 American Academy of Family Physicians continuing medical education credits.
Listen today!